Join us Dec. 1-3 in New Orleans for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
How Delish’s Joanna Saltz built a sizzling brand and hot career in a fickle industry
At a time when media careers are often measured in months rather than years, the editorial director is something of an anomaly.
Buyers aren’t exactly won over by Netflix’s new monthly active viewers (MAV) metric
While Netflix’s intention was more transparency and clarity over reach methodology, marketers aren’t yet confident in how accurate it really is.
Where agencies add value in Amazon’s AI agent-led ad system
Shifts of this scale always create winners and losers. The task for agency bosses is making sure they’re on the right side of that line.